Evidence map›Paper›PMID 37743882›Full record

ReviewCurrent therapeutic research, clinical and experimental2023

Nanoparticles as Potent Agents for Treatment of

Pegah Shakib, Masoomeh Zivdari, Amal Khudair Khalaf, Abdolrazagh Marzban, Mazdak Ganjalikhani-Hakemi, Jahanbakhsh Parvaneh, Hossein Mahmoudvand, Kourosh Cheraghipour

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current therapeutic research, clinical and experimental, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Mechanistic insights intoJournal of advanced veterinary and animal research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pegah ShakibRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Masoomeh ZivdariRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Amal Khudair KhalafDepartment of Microbiology, College of Medicine, University of Thiqar, Iraq.
Abdolrazagh MarzbanRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mazdak Ganjalikhani-HakemiDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Jahanbakhsh ParvanehLorestan Provincial Veterinary Service, Khorramabad, Iran.
Hossein MahmoudvandHepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Kourosh CheraghipourRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes of the genus Objective: The aim of this systematic study was an overview of the treatment of diseases caused by Methods: In the present systematic research with keywords " Results: In the initial search, 250 studies were selected. Based on the inclusion and exclusion criteria, 27 articles were finally selected after removing duplicate, unrelated, and articles containing full text. In present article, the most nanoparticles used against Conclusions: The results indicate the high potential of various nanoparticles, including metal nanoparticles, against

Indexed as

In vitroIn vivoNanoparticlesSchistosomaSystematic review

Identifiers

PMID37743882
PMCPMC10511339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.